MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/lupus-2022-000779

Медицинская библиотека · Lupus science & medicine · 2022

Comparison of short interval and low dose (SILD) with high dose of cyclophosphamide in the susceptibility to infection in SLE: a multicentrereal-world study.

Shao Miao, Miao Miao, Zhang Xia, Zhang Xiaoying, An Yuan, Guo Huifang, Lei Lingyan, Zhao Qing, Ding Yanjie, Lin Jin, Wu Rui, Yu Feng, Li Yucui, Miao Huali, Zhang Liyun, Du Yan, Jiao Ruiying, Pang Lixia, Long Li, Yao Xueming, Shi Xiaofei, Wang Fei, Cui Luping, Zhang Lei, Liu Shengyun, Lu Fuai, Luo Kangkai, Zhao Simeng, Wang Yongfu, Wu Xiao, Wang Qingwen, Liu Hongjiang, Song Shulin, Zhou Xiaoyuan, Zhang Xiaoping, Shi Shumei, Zhu Hong, Chen Yao, Yu Honglian, Wu Jie, Yu Ruiyun, Fan Wenqiang, Liu Shuang, Xu Jian, Chen Zhibin, Shi Lianjie, He Jing, Zhang Xuewu, Li Zhanguo, Li Ru

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVE

Infection is a major cause of death in patients with SLE. This study aimed to explore the infection rate in patients with SLE receiving a low dose of intravenous cyclophosphamide (IV-CYC).

METHODS

Clinical parameters of 1022 patients with SLE from 24 hospitals in China were collected. Patients were divided into the short-interval and lower-dose (SILD, 400 mg every 2 weeks) IV-CYC group and the high-dose (HD, 500 mg/m2 of body surface area every month) IV-CYC group. The clinical data and infection rate between the two groups were compared.

RESULTS

Compared with HD IV-CYC, the infection rate of the SILD IV-CYC group was significantly lower (13.04% vs 22.27%, p=0.001). Respiratory tract infection (10.28% vs 15.23%, p=0.046) and skin/soft tissue infection (1.78% vs 4.3%, p=0.040) were significantly decreased in the SILD IV-CYC group. Moreover, infections occurred most likely in patients with SLE with leucopenia (OR 2.266, 95% CI 1.322 to 3.887, p=0.003), pulmonary arterial hypertension (OR 2.756, 95% CI 1.249 to 6.080, p=0.012) and >15 mg/day of glucocorticoid (OR 2.220, 95% CI 1.097 to 4.489, p=0.027).

CONCLUSIONS

SILD IV-CYC showed a lower frequency of infection events than high-dose IV-CYC in patients with SLE.

Для цитирования: Shao Miao, Miao Miao, Zhang Xia, Zhang Xiaoying, An Yuan, Guo Huifang, Lei Lingyan, Zhao Qing, Ding Yanjie, Lin Jin, Wu Rui, Yu Feng, Li Yucui, Miao Huali, Zhang Liyun, Du Yan, Jiao Ruiying, Pang Lixia, Long Li, Yao Xueming, Shi Xiaofei, Wang Fei, Cui Luping, Zhang Lei, Liu Shengyun, Lu Fuai, Luo Kangkai, Zhao Simeng, Wang Yongfu, Wu Xiao, Wang Qingwen, Liu Hongjiang, Song Shulin, Zhou Xiaoyuan, Zhang Xiaoping, Shi Shumei, Zhu Hong, Chen Yao, Yu Honglian, Wu Jie, Yu Ruiyun, Fan Wenqiang, Liu Shuang, Xu Jian, Chen Zhibin, Shi Lianjie, He Jing, Zhang Xuewu, Li Zhanguo, Li Ru. Comparison of short interval and low dose (SILD) with high dose of cyclophosphamide in the susceptibility to infection in SLE: a multicentrereal-world study.. Lupus science & medicine. 2022. DOI: 10.1136/lupus-2022-000779.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.